These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 15072729

  • 1. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study.
    Zhang Y, Howard BV, Cowan LD, Welty TK, Schaefer CF, Wild RA, Yeh J, Lee ET.
    J Womens Health (Larchmt); 2004 Mar; 13(2):155-63. PubMed ID: 15072729
    [Abstract] [Full Text] [Related]

  • 2. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 Mar; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 3. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 4. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women.
    Piché ME, Lemieux S, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J.
    Am J Cardiol; 2005 Jul 01; 96(1):92-7. PubMed ID: 15979442
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW, Stachenko S, MacLean DR, Petrasovits A, Little JA.
    Can J Cardiol; 1999 Apr 01; 15(4):419-27. PubMed ID: 10322251
    [Abstract] [Full Text] [Related]

  • 6. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep 01; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 7. Plasma lipoprotein levels as predictors of cardiovascular death in women.
    Bass KM, Newschaffer CJ, Klag MJ, Bush TL.
    Arch Intern Med; 1993 Oct 11; 153(19):2209-16. PubMed ID: 8215724
    [Abstract] [Full Text] [Related]

  • 8. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Bingol B, Gunenc Z, Yilmaz M, Biri A, Tiras B, Güner H.
    Arch Gynecol Obstet; 2010 May 11; 281(5):857-64. PubMed ID: 19593578
    [Abstract] [Full Text] [Related]

  • 9. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.
    Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL, THROMBO Investigators.
    J Thromb Haemost; 2004 May 11; 2(5):718-25. PubMed ID: 15099276
    [Abstract] [Full Text] [Related]

  • 10. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M.
    N Engl J Med; 1993 Apr 15; 328(15):1069-75. PubMed ID: 8384316
    [Abstract] [Full Text] [Related]

  • 11. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar 15; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 12. Hostility and physiological risk in the National Heart, Lung, and Blood Institute Family Heart Study.
    Knox SS, Weidner G, Adelman A, Stoney CM, Ellison RC.
    Arch Intern Med; 2005 Mar 15; 164(22):2442-8. PubMed ID: 15596634
    [Abstract] [Full Text] [Related]

  • 13. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP, Madsen JS, Langdahl B, Bladbjerg EM, Tofteng CL, Abrahamsen B, Rejnmark L, Brixen K, Christensen K, Jespersen J, Kristensen SR.
    Thromb Haemost; 2007 Feb 15; 97(2):234-9. PubMed ID: 17264952
    [Abstract] [Full Text] [Related]

  • 14. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J.
    Circulation; 2004 Nov 02; 110(18):2824-30. PubMed ID: 15492318
    [Abstract] [Full Text] [Related]

  • 15. Triglycerides as an early pathophysiological marker of endothelial dysfunction in nondiabetic women with a previous history of gestational diabetes.
    Sokup A, Góralczyk B, Góralczyk K, Rość D.
    Acta Obstet Gynecol Scand; 2012 Feb 02; 91(2):182-8. PubMed ID: 21954994
    [Abstract] [Full Text] [Related]

  • 16. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA, Breda V, Lhullier F, Spritzer PM.
    Metabolism; 2008 Jul 02; 57(7):961-5. PubMed ID: 18555838
    [Abstract] [Full Text] [Related]

  • 17. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
    Im JA, Lee JW, Lee HR, Lee DC.
    Maturitas; 2006 Apr 20; 54(1):65-71. PubMed ID: 16198517
    [Abstract] [Full Text] [Related]

  • 18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 20; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 19. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA.
    J Am Diet Assoc; 2008 Jun 20; 108(6):948-59. PubMed ID: 18502225
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F, Ozgen AG, Yilmaz C, Tüzün M.
    Anadolu Kardiyol Derg; 2007 Dec 20; 7(4):371-7. PubMed ID: 18065331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.